Abstract | BACKGROUND:
Chondroitin sulphate (CS) is an important structural component of cartilage and is approved and regulated as a symptomatic slow-acting drug for osteoarthritis (OA) (SYSADOA) in Europe and some other countries. Although numerous studies have shown the clinical benefits of CS to decrease pain, improve functional disability, reduce non-steroidal anti-inflammatory drug ( NSAID) or acetaminophen consumption, and good tolerability with an additional carry-over effect, there are still some concerns regarding its effectiveness in treating OA. PURPOSE: To examine the data provided by meta-analyses to clarify the effectiveness of CS as a symptomatic treatment for OA. METHODS: A MEDLINE database search was conducted for appropriate meta-analyses published between 1997 and 2007. Five meta-analyses that limited their analysis to randomised controlled trials (RCTs) comparing CS with placebo or no-treatment control arms were retrieved. RESULTS: Four meta-analyses showed significant clinical effects of CS compared with placebo for pain and function measures and one demonstrated greater reduction of analgesic co-medication in patients assigned to the active treatment. In one meta-analysis, the 20 trials included in the study showed a high degree of heterogeneity and the conclusion that CS showed minimal symptomatic benefits was based on the analysis of only three trials. One meta-analysis showed that pain relief after CS treatment steadily increased between 4 and 12 weeks of treatment, whereas the time course of pain relief after treatment with NSAIDs decreased. Two meta-analyses reported consistently higher frequencies of side effects in the placebo group than in patients treated with CS. CONCLUSION: Data provided by these meta-analyses indicate that CS has a slight to moderate efficacy in the symptomatic treatment of OA, with an excellent safety profile.
|
Authors | Jordi Monfort, Johanne Martel-Pelletier, Jean-Pierre Pelletier |
Journal | Current medical research and opinion
(Curr Med Res Opin)
Vol. 24
Issue 5
Pg. 1303-8
(May 2008)
ISSN: 1473-4877 [Electronic] England |
PMID | 18416884
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Aged
- Chondroitin Sulfates
(administration & dosage)
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Humans
- Male
- Meta-Analysis as Topic
- Middle Aged
- Osteoarthritis
(diagnosis, drug therapy)
- Pain Measurement
(drug effects)
- Prognosis
- Randomized Controlled Trials as Topic
- Range of Motion, Articular
(drug effects, physiology)
- Recovery of Function
- Severity of Illness Index
- Treatment Outcome
|